Cargando…

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?

BACKGROUND: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradia...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiner, Waldemar, Dudek, Wojciech, Lettmaier, Sebastian, Fietkau, Rainer, Sirbu, Horia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717585/
https://www.ncbi.nlm.nih.gov/pubmed/26781697
http://dx.doi.org/10.1186/s13019-016-0396-0
_version_ 1782410678226649088
author Schreiner, Waldemar
Dudek, Wojciech
Lettmaier, Sebastian
Fietkau, Rainer
Sirbu, Horia
author_facet Schreiner, Waldemar
Dudek, Wojciech
Lettmaier, Sebastian
Fietkau, Rainer
Sirbu, Horia
author_sort Schreiner, Waldemar
collection PubMed
description BACKGROUND: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradiation is limited. We present our series of salvage lung resections for local NSCLC relapse after curative–intent chemoradiation for locally advanced tumor. METHODS: Nine consecutive patients with local tumor recurrence or persistence following definitive chemoradiation were reviewed. Kaplan-Meier analysis was used to assess patient survival. RESULTS: All patients received definitive radiation (median dose 66.2 Gy) with concurrent chemotherapy. Tumor stage prior to chemoradiation was IIIA in 8 patients and IV in 1. In 4 patients tumor invaded the chest wall, in 2 the spine and in 1 the aorta. Median interval between chemoradiation and salvage resection was 30.2 weeks. Nine patients underwent 9 resections (6 lobectomies, 1 bilobectomy, 1 pneumonectomy and 1 bi-segmentectomy). One death occurred on the 12th postoperative day. Median overall survival was 23 months; postoperative 3-year survival was 47 %. Median progression-free survival was 21 months. CONCLUSION: Salvage lung resection for locally recurrent or persisted NSCLC in selected patients with locally advanced NSCLC following definitive chemoradiation is a worthwhile treatment option.
format Online
Article
Text
id pubmed-4717585
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47175852016-01-20 Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? Schreiner, Waldemar Dudek, Wojciech Lettmaier, Sebastian Fietkau, Rainer Sirbu, Horia J Cardiothorac Surg Research Article BACKGROUND: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradiation is limited. We present our series of salvage lung resections for local NSCLC relapse after curative–intent chemoradiation for locally advanced tumor. METHODS: Nine consecutive patients with local tumor recurrence or persistence following definitive chemoradiation were reviewed. Kaplan-Meier analysis was used to assess patient survival. RESULTS: All patients received definitive radiation (median dose 66.2 Gy) with concurrent chemotherapy. Tumor stage prior to chemoradiation was IIIA in 8 patients and IV in 1. In 4 patients tumor invaded the chest wall, in 2 the spine and in 1 the aorta. Median interval between chemoradiation and salvage resection was 30.2 weeks. Nine patients underwent 9 resections (6 lobectomies, 1 bilobectomy, 1 pneumonectomy and 1 bi-segmentectomy). One death occurred on the 12th postoperative day. Median overall survival was 23 months; postoperative 3-year survival was 47 %. Median progression-free survival was 21 months. CONCLUSION: Salvage lung resection for locally recurrent or persisted NSCLC in selected patients with locally advanced NSCLC following definitive chemoradiation is a worthwhile treatment option. BioMed Central 2016-01-19 /pmc/articles/PMC4717585/ /pubmed/26781697 http://dx.doi.org/10.1186/s13019-016-0396-0 Text en © Schreiner et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Schreiner, Waldemar
Dudek, Wojciech
Lettmaier, Sebastian
Fietkau, Rainer
Sirbu, Horia
Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
title Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
title_full Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
title_fullStr Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
title_full_unstemmed Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
title_short Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
title_sort should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717585/
https://www.ncbi.nlm.nih.gov/pubmed/26781697
http://dx.doi.org/10.1186/s13019-016-0396-0
work_keys_str_mv AT schreinerwaldemar shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer
AT dudekwojciech shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer
AT lettmaiersebastian shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer
AT fietkaurainer shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer
AT sirbuhoria shouldsalvagesurgerybeconsideredforlocalrecurrenceafterdefinitivechemoradiationinlocallyadvancednonsmallcelllungcancer